GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Gross Margin %

Abbott India (BOM:500488) Gross Margin % : 43.98% (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Abbott India's Gross Profit for the three months ended in Mar. 2024 was ₹6,327 Mil. Abbott India's Revenue for the three months ended in Mar. 2024 was ₹14,386 Mil. Therefore, Abbott India's Gross Margin % for the quarter that ended in Mar. 2024 was 43.98%.


The historical rank and industry rank for Abbott India's Gross Margin % or its related term are showing as below:

BOM:500488' s Gross Margin % Range Over the Past 10 Years
Min: 40.82   Med: 43.29   Max: 45.88
Current: 44.94


During the past 13 years, the highest Gross Margin % of Abbott India was 45.88%. The lowest was 40.82%. And the median was 43.29%.

BOM:500488's Gross Margin % is ranked worse than
54.36% of 986 companies
in the Drug Manufacturers industry
Industry Median: 47.02 vs BOM:500488: 44.94

Abbott India had a gross margin of 43.98% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Abbott India was 0.90% per year.


Abbott India Gross Margin % Historical Data

The historical data trend for Abbott India's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India Gross Margin % Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.40 44.50 45.88 44.38 44.94

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.41 44.32 45.50 45.95 43.98

Competitive Comparison of Abbott India's Gross Margin %

For the Drug Manufacturers - General subindustry, Abbott India's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Abbott India's Gross Margin % falls into.



Abbott India Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Abbott India's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=26283 / 58489.1
=(Revenue - Cost of Goods Sold) / Revenue
=(58489.1 - 32206.1) / 58489.1
=44.94 %

Abbott India's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=6327.3 / 14386.3
=(Revenue - Cost of Goods Sold) / Revenue
=(14386.3 - 8059) / 14386.3
=43.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Abbott India  (BOM:500488) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Abbott India had a gross margin of 43.98% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Abbott India Gross Margin % Related Terms

Thank you for viewing the detailed overview of Abbott India's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines